Quick View
Loading...
Dragon Pharma
Estimated Delivery: 12-26 Days (International), 3-6 Days (United States)
Return within 45 Days of purchase. Duties & taxes are non-refundable.
Buy Klow Blend peptide 80 mg by Dragon Pharma at XSteroids. Klow is the four-peptide version of the repair blend: GHK-Cu, BPC-157 and TB-500, plus KPV, the alpha-MSH fragment associated with anti-inflammatory signalling. Dragon Pharma supplies it as an 80 mg lyophilized vial. This guide covers what is in it, what KPV actually is, klow peptide dosage practice and how the vial is prepared.
None of the four peptides is approved for human use and the combination has never been studied clinically, so the information below is educational only.
Klow takes the formula behind the Glow blend and adds a fourth peptide. That is why the vial is 80 mg rather than 60 mg: the extra component has to fit alongside the other three. The mix is a commercial formulation rather than a tested pharmaceutical product, and the exact split is printed on the vial label.
In practice the blend is positioned as skin, hair and repair support with an anti-inflammatory angle - the part KPV is there for.
KPV is the C-terminal tripeptide of alpha-MSH, made of lysine, proline and valine. According to the peptide literature, most of the anti-inflammatory activity of alpha-MSH can be attributed to this small C-terminal fragment - it is a three-amino-acid peptide that carries a disproportionate share of the parent hormone's signalling role. Research in this area covers gut and skin inflammation, and NF-kB inhibition is the mechanism most often cited.
The other three are the repair core. GHK-Cu is the copper tripeptide studied for collagen and skin, present in plasma at around 200 ng/mL in a 20-year-old. BPC-157 is the fifteen-amino-acid peptide from gastric juice with pre-clinical cytoprotective and healing activity, not approved and with an unresolved angiogenesis question. TB-500 is a fragment of thymosin beta-4, the actin-binding protein whose repair properties drove clinical wound-healing trials.
Because this is a four-peptide blend, no clinical dose exists - the formulation has never been tested as a product. Practice combines each peptide's individual research range into a single daily injection, and the higher 80 mg vial content means the reconstitution maths matters more: with more powder in the vial, the same water volume produces a more concentrated solution, and the dose is measured in micrograms.
Mix the lyophilized powder with bacteriostatic water, aiming the stream at the vial wall rather than the powder, then swirl gently instead of shaking. Label the vial with the date, keep it refrigerated, and treat a punctured multi-dose vial as usable for 28 days after the first puncture.
There is no studied safety profile for the combination. At component level, GHK-Cu raises a theoretical copper-load question, BPC-157 has the unresolved angiogenesis discussion, KPV is the least documented in human terms of the four, and none of them carries regulatory approval. Because the protocol is a single daily injection of a blend, any reaction is hard to attribute to one peptide - a genuine limitation of combination vials.
The difference is simple: Glow contains GHK-Cu, BPC-157 and TB-500; Klow adds KPV and arrives as an 80 mg vial instead of 60 mg. If the goal is skin and hair only, Glow covers it with fewer variables. The BPC-157 and TB-500 blend is the two-peptide option, and the single vials (GHK-Cu, BPC-157, TB-500) let you control the ratio yourself.
Store the lyophilized vial in a cool, dry place away from direct light before reconstitution. After mixing with bacteriostatic water, keep the solution refrigerated and use it within the recommended period for peptide solutions. Keep vials out of the reach of children.
At XSteroids you buy the Dragon Pharma Klow Blend vials directly from the brand catalog, with secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Browse the full range on the Dragon Pharma brand page to complete your research stack.
Klow is a four-peptide blend: GHK-Cu, BPC-157, TB-500 and KPV. Dragon Pharma supplies it as an 80 mg lyophilized vial. It is a commercial formulation rather than a clinically tested pharmaceutical product. The four-peptide mix has never been studied as a whole.
The same three repair peptides as the Glow blend - GHK-Cu, BPC-157 and TB-500 - plus KPV, the C-terminal tripeptide of alpha-MSH that carries much of the parent hormone anti-inflammatory activity, including NF-kB inhibition and reduced inflammatory cell infiltration in research models.
There is no clinical dose, because the blend has never been tested as a product. Practice draws on each peptide research range and delivers them in one daily injection. With an 80 mg vial, the reconstitution maths matters more than with smaller blends.
Klow adds KPV to the three peptides in Glow and comes as an 80 mg vial instead of 60 mg. If the goal is skin and hair only, Glow covers it with fewer variables; Klow is the version with the anti-inflammatory component.
Mix the powder with bacteriostatic water, aiming the stream at the vial wall, then swirl gently rather than shaking. Label the vial with the date, keep it refrigerated, and treat a punctured multi-dose vial as usable for 28 days after the first puncture.
There is no studied safety profile for the combination. At component level there is a theoretical copper-load question with GHK-Cu and an unresolved angiogenesis discussion around BPC-157, while KPV is the least documented of the four in human terms. No human trials of the blend exist.
You can buy the Klow Blend 80 mg vial by Dragon Pharma online at XSteroids. The store offers secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. Add the vial to your cart on this page.
Loading...
Your cart is currently empty. Let us assist you in finding the right product